DVC Venture Capital
As of January 2004 Dr Jan zur Hausen has joined the life sciences team of DVC as a partner. He has international and operational experience in the fields of venture capital and M&A, as well as within the pharmaceutical industry. In 2000 he began to work as managing director for the investment firm Mulligan BioCapital in Hamburg, where he was co-responsible for putting together a diversified portfolio of ten European and US biotechnology companies.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








